Growth & Assumptions
Market & Balance Sheet Data
Cash Flow Projection
Valuation Breakdown
Calculated Fair Value
CME (CME) DCF Valuation Analysis
Independent intrinsic value calculation based on latest financial reports.
Our CME DCF calculator utilizes a two-stage Discounted Cash Flow model to estimate the true value of CME stock. As of the most recent quarterly report (3/31/2026), CME generated $4,329,300,000 in Trailing Twelve Month (TTM) Free Cash Flow.
Key Valuation Metrics for CME
By discounting CME's future cash flows using an expected return of 11%, we can determine if the stock is currently trading at a margin of safety. A positive margin of safety suggests that market expectations may be too low relative to the company's historical cash flow productivity.
Final Verdict
For CME to be considered a fair investment at current levels, it would need to sustain a cash flow growth rate of approximately 14.40% for the next five years. This valuation model accounts for CME's current cash position of $2,515,399,936 and total debt of $3,742,200,064. With a fair value of $299.97, CME shows potential upside for long-term investors.
Why use DCF for CME?
Discounted Cash Flow is widely considered the most accurate method for valuing mature companies like CME. Using our Free DCF Calculator, you can customize every assumption in this model to see how it affects the intrinsic value.